Nightstar Therapeutics plc American Depositary Shares
NITE
NITE was delisted on the 6th of June, 2019.
20 hedge funds and large institutions have $118M invested in Nightstar Therapeutics plc American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
25% more funds holding
Funds holding: 16 → 20 (+4)
9% more capital invested
Capital invested by funds: $108M → $118M (+$9.99M)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Ascend Capital
Orinda,
California
|
+$1.65M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.62M |
| 3 |
Millennium Management
New York
|
+$482K |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$417K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$326K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.57M |
| 2 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$845K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$176K |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$53.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12K |
NITE Hedge Fund Activity: Q1 2018 in Review
20 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q1 2018, worth a combined $118M — up 9.2% from $108M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NITE positions and 1 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Ascend Capital, opening a new position worth an estimated $1.65M. The largest seller was Franklin Resources, cutting an estimated $2.57M.
- 20 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q1 2018, up from 16 in Q4 2017.
- Funds reported $118M of Nightstar Therapeutics plc American Depositary Shares stock for Q1 2018, up 9.2% quarter-over-quarter.
- 5 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q1 2018 and 1 closed out, a net change of +4 holders.
- The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q1 2018 was Ascend Capital, an estimated $1.65M added.
- The largest Nightstar Therapeutics plc American Depositary Shares seller in Q1 2018 was Franklin Resources, an estimated $2.57M sold.
Based on aggregated 13F filings for Q1 2018.